Recent Results from the Largest European Impella® Registry

August 27, 2020

The Impact of Extensive Revascularization in Protected PCI and Impella Support in Cardiogenic Shock Treatment

The results of the R-IMP IT (Revascularization Extent in Impella Italian Registry) study were presented by Cristina Aurigemma, MD, PhD (Policlinico Gemelli, Rome) as part of e-PCR 2020. It's a subanalysis of the IMP-IT Registry (Impella Italian Registry) that was presented in the Late Breaking Clinical Trial Session at the EuroPCR in 2019 by Dr. Alaide Chieffo and published in EuroIntervention in 2020. Armin Klesius, MD, PhD, MBA recently spoke with Cristina Aurigemma MD, PhD, Professor Francesco Burzotta, MD, PhD, and Professor Carlo Trani, MD about the background, details and importance of this data in clinical practice.

NPS-853
NPS-982

Subscribe or join the conversation by following us on Twitter: @ProtectedPCI


To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: abiomed.com/important-safety-information

Subscribe to the Digital Community

Receive weekly updates including case review videos, tips and tricks, specialists opinions, and resources and downloads regarding Protected PCI and Cardiogenic Shock.

Subscribe to the Digital Community

Receive weekly updates including case review videos, tips and tricks, specialists opinions, and resources and downloads regarding Protected PCI and Cardiogenic Shock.